Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.86
-1.07 (-6.72%)
At close: Mar 6, 2026, 4:00 PM EST
15.15
+0.29 (1.95%)
After-hours: Mar 6, 2026, 6:37 PM EST
Adaptive Biotechnologies Revenue
In the year 2025, Adaptive Biotechnologies had annual revenue of $276.98M with 54.77% growth. Adaptive Biotechnologies had revenue of $71.68M in the quarter ending December 31, 2025, with 51.04% growth.
Revenue (ttm)
$276.98M
Revenue Growth
+54.77%
P/S Ratio
8.26
Revenue / Employee
$443,872
Employees
624
Market Cap
2.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 276.98M | 98.02M | 54.77% |
| Dec 31, 2024 | 178.96M | 8.68M | 5.10% |
| Dec 31, 2023 | 170.28M | -15.03M | -8.11% |
| Dec 31, 2022 | 185.31M | 30.96M | 20.06% |
| Dec 31, 2021 | 154.34M | 55.96M | 56.88% |
| Dec 31, 2020 | 98.38M | 13.31M | 15.65% |
| Dec 31, 2019 | 85.07M | 29.41M | 52.83% |
| Dec 31, 2018 | 55.66M | 17.22M | 44.77% |
| Dec 31, 2017 | 38.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apellis Pharmaceuticals | 1.00B |
| Telix Pharmaceuticals | 803.79M |
| Travere Therapeutics | 490.73M |
| Beam Therapeutics | 139.74M |
| Ocular Therapeutix | 51.95M |
| Wave Life Sciences | 42.73M |
| Immunome | 6.94M |
| Dianthus Therapeutics | 3.08M |
ADPT News
- 4 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - GlobeNewsWire
- 7 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies spinout raising $15M to develop clinical sequencing tech - GeekWire
- 2 months ago - Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire